U.S. patent number 3,815,315 [Application Number 05/345,604] was granted by the patent office on 1974-06-11 for ethylene oxide sterilization of moisture sensitive surgical elements.
This patent grant is currently assigned to American Cyanamid Company. Invention is credited to Arthur Glick.
United States Patent |
3,815,315 |
Glick |
June 11, 1974 |
**Please see images for:
( Certificate of Correction ) ** |
ETHYLENE OXIDE STERILIZATION OF MOISTURE SENSITIVE SURGICAL
ELEMENTS
Abstract
A dry absorbable synthetic surgical element of a polymer subject
to hydrolytic degradation to non-toxic, tissue-compatible,
absorbable components, such as a polyglycolic acid suture, is
packaged in an air-tight sealed container which is substantially
impervious to water vapor such as a laminate film having a metallic
foil layer. The gaseous contents of the envelope are, prior to
sealing the suture within the envelope, either evacuated or
replaced with a gas which is inert towards said surgical element
and which is substantially free from water. The water content
should be below 0.5 percent by weight of the weight of the surgical
element, and preferably is and remains below 0.05 percent by
weight. Polyglycolic acid sutures and other elements thus packaged
retain acceptable levels of strength for at least one year at
storage temperatures of 72.degree.F. and ambient humidity outside
the package. The contents may be sterilized by using ethylene
oxide.
Inventors: |
Glick; Arthur (Danbury,
CT) |
Assignee: |
American Cyanamid Company
(Stamford, CT)
|
Family
ID: |
26836184 |
Appl.
No.: |
05/345,604 |
Filed: |
March 28, 1973 |
Related U.S. Patent Documents
|
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
Issue Date |
|
|
138425 |
Apr 29, 1971 |
3728839 |
Apr 24, 1974 |
|
|
788501 |
Jan 2, 1969 |
|
|
|
|
Current U.S.
Class: |
53/425; 53/434;
53/440; 53/449; 206/210; 422/34; 206/524.8 |
Current CPC
Class: |
B65D
75/26 (20130101); A61B 17/06133 (20130101); A61L
2/206 (20130101) |
Current International
Class: |
A61L
2/20 (20060101); A61B 17/06 (20060101); B65D
75/26 (20060101); B65b 055/10 () |
Field of
Search: |
;53/21FC,22B ;21/58
;206/63.3 |
References Cited
[Referenced By]
U.S. Patent Documents
Primary Examiner: McGehee; Travis S.
Attorney, Agent or Firm: Walker; Samuel Branch
Parent Case Text
CROSS-REFERENCES
This is a continuation-in-part of my copending application Ser. No.
138,425, filed Apr. 29, 1971, now U.S. Pat. No. 3,728,839, Apr. 24,
1973, which application is a continuation-in-part of application
Ser. No. 788,501 filed Jan. 2, 1969, and abandoned in favor
thereof.
Claims
I claim:
1. In a method for preparing a storage stable sterile package
containing a sterile synthetic surgical element of a polymer
subject to hydrolytic degradation to non-toxic, tissue-compatible
absorbable components, said polymer having glycolic acid ester
linkages, which comprises:
a. inserting a synthetic surgical element of a polymer subject to
hydrolytic degradation to non-toxic, tissue-compatible absorbable
components, said polymer having glycolic acid ester linkages, in a
container which is substantially impervious to water vapor,
b. sterilizing said surgical element and container,
c. removing water until not more than 0.5 percent of water by
weight of said surgical element remains,
d. maintaining said surgical element in its dry environment
and,
e. sealing said container with an air and moisture resistant
seal,
f. the improvement comprising sterilizing said element and
container by contacting with a gas containing about 12 percent by
volume ethylene oxide and 88 percent by volume
dichlorodifluoromethane for 4 to 20 hours at 70.degree. to
100.degree.F. an 5 to 30 psig, said gas having ambient moisture
content, and
g. heating said envelope and its contents for about one hour at
82.degree.-88.degree.C. and an absolute pressure of 1 to 5 mm
Hg.
2. The method of claim 1 in which the sterile surgical element is a
polyglycolic acid suture, and the water content is less than 0.05
percent.
3. The method for making a dual envelope suture package
comprising
1. a sterile, sealed, air-tight moisture proof inner envelope
fabricated from a polyethylene -- aluminum foil -- polyethylene --
paper laminate containing therein a dry sterile polyglycolic acid
suture, the gaseous contents of the inner envelope having been
evacuated to yield a vacuum packaged suture, the inner layer of
said inner envelope being polyethylene and the outer layer being
paper in
2. a strippable outer envelope fabricated from a laminate of
polyethylene and the polymeric ester of ethylene glycol and
terephthalic acid; and wherein the interenvelope space of said dual
envelope package is sterile, which comprises:
a. inserting a polyglycolic acid suture into the inner envelope
described above,
b. sterilizing the inner envelope and its contents by contacting
them with a gas containing about 12 percent by volume ethylene
oxide and 88 percent by volume dichlorodifuloromethane for 4 to 20
hours at 70.degree. to 100.degree.F. and 5 to 30 psig., said gas
having ambient moisture content,
c. heating said envelope and its contents for about one hour at
82.degree.-88.degree.C. and an absolute pressure of 1 to 5 mm
Hg,
d. maintaining the dry suture in a substantially dry and sterile
environment while awaiting completion of packaging,
e. evacuating the gaseous contents of the inner envelope and
sealing said envelope with an air-tight moisture proof seal to
produce a vacuum packaged suture,
f. sealing the sealed inner envelope within the outer envelope
described above to form a dual envelope package, and
g. sterilizing the inter space of the dual envelope package by
contacting the package with a gas containing 12 percent by volume
ethylene oxide and 88 percent by volume dichlorodifluoromethane for
16-24 hours at 72.degree.-100.degree.F. and 10-27 psig, said gas
having an ambient relative humidity, which permeates the seals of
the outer envelope, and sterilizes the interenvelope space.
Description
BACKGROUND OF THE INVENTION
At the present time, virtually all absorbable sutures used in
animal and human surgery are prepared from mammalian intestines,
such sutures being commonly called catgut sutures. U.S. Pat. No.
3,297,033 describes an absorbable surgical suture made from
polyglycolic acid. The disclosure therein is incorporated by
reference. This patent in column 3, lines 20 to 53 disclose other
components which may be present in the suture. As set forth
therein, polyglycolic acid is also properly named as
poly(hydroxyacetic acid) or poly-hydroxyacetic ester or
polyglycolide and can be considered as essentially a product of
polymerization of glycolic acid, that is, hydroxyacetic acid, which
in simplified form is shown by the equation: ##SPC1##
For use as a suture, preferably n is such that the molecular weight
is in the range of 10,000 or more. Above 100,000 the polymer is
difficult to extrude.
In these molecular weight ranges the polymer has a melt viscosity
at 245.degree.C. of between about 400 and about 27,000 poises.
Because the fiber is from a synthetic and controllable source, with
a controlled molecular weight and is a homopolymer or has a
controllable small percentage of comonomer, the absorbability,
stiffness and other characteristics can be modified. In general,
the higher the molecular weight, the slower the rate of absorption
under a given set of conditions.
Among several methods by which polyhydroxyacetic ester can be
prepared, one preferred route involves the polymerization of
glycolide, ##SPC2##
The cyclic dimeric condensation product formed by dehydrating
hydroxyacetic acid. During polymerization of glycolide, the ring is
broken and straight-chain polymerization occurs. Probably at least
a small portion of the polymerization involves the formation of
anhydride or ether linkages from a condensation of glycolic acid in
a head-to-head, or tail-to-tail direction. The current state of the
art is not sufficiently advanced to show with certainty the ratio
of anhydride or ether linkages to ester group but indicates these
are no more than a few percent of the total. A small quantity of
methoxyacetic acid, ##SPC3##
or methyl hydroxyacetic ester, ##SPC4##
or their homologs, such as higher alkoxyacetic acids, or alkyl
hydroxyacetic esters may be present during the polymerization as an
end group stabilizer controlling the molecular weight and
viscosity. Small quantities of other materials may be present in
the chain, as for example d, 1-lactic acid, its optically active
forms, homologs, and analogs.
Said U.S. Pat. No. 3,297,033 incorporates a reference to U.S. Pat.
No. 2,668,162 -- Lowe which quantifies a small amount of lactides
as up to 15 percent, disclosing for example the preparation of a
copolymer of 90/10 glycolide/lactide offers two advantages over the
homopolymer of glycolide. One advantage is that the melting point
of the copolymer is lower than the homopolymer, being in the
neighborhood of 200.degree.C.; and the entire reaction can be
conducted at approximately the melting point of the copolymer.
Operation at the lower temperatures decreases the rate of
degradation of the polymer which gives a polymer of lighter color.
Another advantage is that the copolymer can be successfully
quenched when being extruded into film because the copolymer is
less crystalline. On the other hand, the homopolymer shows a
greater tendency to crystallize on extrusion and thereby tends to
form opaque areas in the film.
Example 4 of said U.S. Pat. No. 2,668,162 shows reaction
conditions.
Surgical elements of polyglycolic acid, including sutures, and
other elements mentioned below can be better seen in most surgical
fields if the element is colored so as to contrast with blood and
tissue or bandages or other background materials.
BRIEF DESCRIPTION OF PRIOR ART
Surgical sutures and other surgical elements containing polymers of
glycolic acid are described in:
U.S. Pat. No. 3,297,033, Jan. 10, 1967, Schmitt and Polistina,
SURGICAL SUTURES.
U.S. Pat. No. 3,463,158, Aug. 26, 1969, Schmitt and Polistina,
POLYGLYCOLIC ACID PROSTHETIC DEVICES.
U.S. Pat. No. 3,565,077 -- Feb. 23, 1971, Glick, DENSIFIED
ABSORBABLE POLYGLYCOLIC ACID SUTURE BRAID, AND METHOD FOR PREPARING
SAME
U.S. Pat. No. 3,620,218, Nov. 16, 1971, Schmitt and Polistina,
CYLINDRICAL PROSTHETIC DEVICES OF POLYGLYCOLIC ACID.
U.S. Pat. No. 3,626,948, Dec. 14, 1971, Glick and McPherson,
ABSORBABLE POLYGLYCOLIC ACID SUTURE OF ENHANCED IN-VIVO STRENGTH
RETENTION.
U.S. Pat. No. 3,728,739, Apr. 24, 1973, Semp, STERILE SURGICAL
GLOVES.
Reference is made to these patents which show additional prior art
and for the definitions therein set forth.
Related data incorporated herein by this reference on manufacturing
of polyglycolic acid, producing surgical elements thereof and its
use for surgical purposes are disclosed in:
U.S. Pat. No. 3,414,939 -- Dec. 10, 1968, Chirgwin, APPARATUS FOR
QUENCHING MELT-SPUN FIBERS.
U.S. Pat. No. 3,422,181 -- Jan. 14, 1969, Chirgwin, METHOD FOR HEAT
SETTING OF STRETCH ORIENTED POLYGLYCOLIC ACID FILAMENT.
U.S. Pat. No. 3,435,008 -- Mar. 25, 1969, Schmitt, Epstein and
Polistina, METHOD FOR PREPARATION OF ISOMERICALLY PURE
.beta.-GLYCOLIDE AND POLYMERIZATION METHOD FOR GLYCOLIDE
COMPOSITIONS EMPLOYING PARTIAL HYDROLYZATE OF SAID
.beta.-GLYCOLIDE.
U.S. Pat. No. 3,442,871 -- May 6, 1969, Schmitt, Epstein and
Polistina, PROCESS FOR POLYMERIZING A GLYCOLIDE.
U.S. Pat. No. 3,457,280 -- July 22, 1969, Schmitt, Epstein and
Polistina, .alpha.-GLYCOLIDE AND METHODS FOR THE ISOLATION
THEREOF.
U.S. Pat. No. 3,468,853 -- Sept. 23, 1969, Schmitt and Polistina,
PROCESS OF POLYMERIZING A GLYCOLIDE.
U.S. Pat. No. 3,565,869 -- Feb. 23, 1971, DeProspero, EXTRUDABLE
AND STRETCHABLE POLYGLYCOLIC ACID AND PROCESS FOR PREPARING
SAME.
U.S. Pat. No. 3,597,449, Aug. 3, 1971, DeProspero and Schmitt,
STABLE GLYCOLIDE AND LACTIDE COMPOSITIONS.
U.S. Pat. No. 3,597,450, Aug. 3, 1971, Schmitt, Polistina, Epstein
and DeProspero, PREPARATION OF GLYCOLIDE POLYMERIZABLE INTO
POLYGLYCOLIC ACID OF CONSISTENTLY HIGH MOLECULAR WEIGHT.
U.S. Pat. No. 3,600,223, Aug. 17, 1971, Glick and McCusker, PROCESS
FOR CLEANING POLYGLYCOLIC ACID FILAMENTS USEFUL AS ABSORBABLE
SURGICAL SUTURES.
U.S. Ser. No. 34,593, May 4, 1970, Schmitt and Bailey, SOLUTIONS OF
POLYGLYCOLIC ACID, now abandoned.
U.S. Ser. No. 118,974, Feb. 25, 1971, Ramsey and Delapp,
PREPARATION OF POLYGLYCOLIC ACID IN FINELY DIVIDED FORM, now U.S.
Pat. No. 3,781,349, Dec. 25, 1973.
U.S. Ser. No. 157,521, June 28, 1971, Schmitt and Polistina,
POLYGLYCOLIC ACID PROSTHETIC DEVICE, now U.S. Pat. No. 3,739,773,
June 19, 1973.
U.S. Ser. No. 171,320, Aug. 12, 1971, Schmitt and Bailey,
POLYGLYCOLIC ACID IN SOLUTIONS, now U.S. Pat. No. 3,737,440, June
5, 1973.
U.S. Ser. No. 176,291, Aug. 30, 1971, Glick and Chirgwin, DOPE-DYED
POLYGLYCOLIC ACID SUTURES.
U.S. Ser. No. 190.290, Oct. 18, 1971, Schmitt and Epstein, now U.S.
Pat. No. 3,736,646, June 5, 1973, METHOD OF ATTACHING SURGICAL
NEEDLES TO MULTIFILAMENT POLYGLYCOLIC ACID ABSORBABLE SUTURES.
U.S. Ser. No. 277,537, Aug. 3, 1972, Glick and Chirgwin, GREEN
POLYGLYCOLIC ACID SUTURES AND SURGICAL ELEMENTS.
Other United States and foreign patents disclose surgical elements
in hich biodegradability and absorption results from the hydrolytic
attack of tissue components on glycolic acid ester linkages in the
polymer composing such surgical elements.
Polyglycolic sutures exhibit great uniformity of composition, as
compared with catgut. They have excellent package strength, i.e.
straight pull and knot pull, and desirable in-vivo strength
retention.
It has now been found that the desirable package properties and
in-vivo properties of polyglycolic acid surgical elements such as
sutures deteriorate when exposed to moisture. Surprising, the
exposure of dry polyglycolic acid sutures to small amounts of
moisture for very short periods of time is sufficient to cause
serious deterioration in the package and in-vivo strength of the
sutures on long term standing.
If the polyglycolic acid suture for instance is again dried before
packaging, the storage stability is regained. For instance,
polyglycolic acid filaments may be braided at ambient temperature
and humidity, in a New England climate, and if the finished braid
is dried to remove all absorbed moisture, the dried braid is
storage stable. For process uniformity and operator comfort, an air
conditioned environment is preferred.
Although the reason for the aforementioned effect of moisture on
the properties of polyglycolic acid sutures is not known with
certainty, it is believed that several mechanisms may be involved.
First, the water may hydrolytically attack the polymer structure to
thereby degrade and weaken the polymer. It is also possible that
the water may be reacting with unreacted glycolide monomer which an
be present in the polymer in an amount up to about 8 percent to
cleave the glycolide ring structure into the linear dimer of
glycolic acid which is represented by the following formula:
##SPC5##
The linear dimer in turn can react with the polymer to break up the
high molecular weight polymer into lower molecular weight chains
thereby degrading the polymer and causing a reduction in strength.
It is also possible that glycolide or the linear dimer of glycolic
acid are formed in the polymer as a result of thermal degradation
of the polymer which can occur during processing such as, for
example, in a high temperature extrusion step.
The exact mechanism of hydrolytic attack is somewhat speculative,
and not critical to an explanation or understanding of the present
invention. One explanation of the hydrolytic attack is that two
glycolic acid units can twist to cause a carbonyl carbon to be
sterically approached by the second nearest oxygen in the backbone
of the polymer and incipiently form a six membered ring. This
anchiomeric attack weakens that carbonyl-oxygen bond, contributing
towards hydrolysis of the bond, which thus breaks the polymer
chain. [See: Mechanism and Structure in Organic Chemistry, Edwin S.
Gould, Holt, Rinehart and Winston, N.Y., 1959, page 562 and
reference therein to Winstein, Lindegren, Marshall and Ingraham, J.
Am. Chem. Soc. 75, 147 (1953)].
Glycolic acid links in any polymeric chain, particularly those
having incipient six membered rings, contribute towards hydrolysis,
and fragmentation of the polymer chain into links small enough to
be handled by tissue chemistry. The fragmentation is hydrolytic,
and does not require an enzyme system. The degradation of catgut
requires an enzyme system.
In commercial use, a suture may not be used for months or sometimes
years after it is packaged. In the meantime, the suture package may
be stored under a variety of environmental conditions. Most of
these storage environments expose the package to some moisture. It
is mandatory that such sutures be packaged in a material which will
prevent permeation of water vapor from the environment surrounding
the package through the package and into contact with the suture
contained therein. On the other hand, a package material which
prevents the entry of water vapor will ordinarily also prevent the
exit of water vapor; therefore, any water vapor which is present
within the package when it is sealed will remain in the package in
intimate contact with the suture. Applicant has further discovered
that the exposure of a dry suture to moisture for even extremely
brief times (i.e. 20 minutes or less) prior to packaging the suture
can have deleterious effects upon the suture when it is packaged in
a water impermeable package, especially if the package should
happen to be stored at elevated temperatures.
While primarily for sutures, other polyglycolic acid prosthetic
devices need to be stored from time of manufacture until time of
use.
As disclosed in said U.S. Pat. No. 3,297,033, the polyglycolic acid
may be formed as tubes or sheets for surgical repair and may also
be spun as thin filaments and woven or felted to form absorbable
sponges or absorbable gauze, or used in conjunction with other
compressive structures as prosthetic devices within the body of a
human or animal where it is desirable that the structure have
short-term strength, but be absorbable. The useful embodiments
include tubes, including branched tubes or Tees, for artery, vein
or intestinal repair, nerve splicing, tendon splicing, sheets for
tying up and supporting damaged kidney, liver and other intestinal
organs, protecting damaged surface areas such as abrasions,
particularly major abrasions, or areas where the skin and
underlying tissues are damaged or surgically removed.
In more detail, the medical uses of polyglycolic acid include, but
are not necessarily limited to:
1. Solid Products, molded or machined
a. Orthopedic pins, clamps, screws and plates
b. Clips (e.g., for vena cava)
c. Staples
d. Hooks, buttons and snaps
e. Bone substitutes (e.g., mandible prosthesis)
f. Needles
g. Non-permanent intrauterine devices (spermocide)
h. Temporary draining or testing tubes or capillaries
i. Surgical instruments
j. Vascular implants or supports
k. Vertebral discs
l. Extracorporeal tubing for kidney and heart-lung machines
2. Fibrillar Products, knitted or woven, including velours
a. Burn dressings
b. Hernia patches
c. Absorbent paper or swabs
d. Medicated dressings
e. Facial substitutes
f. Gauze, fabric, sheet, felt or sponge for liver hemostasis
g. Gauze bandages
h. Dental packs
i. Sutures, including ligatures
3. Miscellaneous
a. Flake or powder for burns or abrasions
b. Foam as absorbable prosthesis
c. Substituted for wire in fixations
d. Film spray for prosthetic devices
In Combination with other Components
1. Solid Products, molded or machined
a. Slowly digestible ion-exchange resin
b. Slowly digestible drug release device (pill, pellet)
c. Reinforced bone pins, needles, etc.
2. Fibrillar Products
a. Arterial graft or substitutes
b. Bandages for skin surfaces
c. Burn dressings (in combination with other polymeric films.)
The synthetic character and hence predictable formability and
consistency in characteristics obtainable from a controlled process
are highly desirable.
The most convenient method of sterilizing polyglycolic acid
prostheses is by heat under such conditions that any microorganisms
or deleterious materials are rendered inactive. A second common
method is to sterilize using a gaseous sterilizing agent such as
ethylene oxide. Other methods of sterilizing include radiation by
X-rays, gamma rays, neutrons, electrons, etc., or high intensity
ultrasonic vibrational energy or combinations of these methods. The
present materials have such physical characteristics that they may
be sterilized by any of these methods.
Strippable packages for sutures are described in U. S. Pat. No.
3,043,067, Rynkiewicz and Ayres, Suture Package; U.S. Pat. No.
2,917,878, Carnarius and Kaufman, Method of Sterile Packing and
U.S. Pat. No. 2,949,181, Suture Package and Process of Making Same.
U.S. Pat. No. 2,734,649, Callahan and Rumpf, Moistureproof Vial
Closure, shows an appreciation of the type of protection required
for moisture sensitive materials.
It is an object of this invention to provide a package for
polyglycolic acid products which insures acceptable retention of
package and in-vivo strength for prolonged periods of time even
under the most undesirable conditions of temperature and humidity.
It is another object of this invention to provide a method of
sterilizing polyglycolic acid surgical elements using ethylene
oxide.
SUMMARY OF THE INVENTION
The present invention is predicated upon the surprising and
unexpected discovery that polyglycolic acid is extremely sensitive
to hydrolytic attack, and that while for a period of weeks to
months, depending on the temperature, may retain a high proportion
of its strength, in the presence of as much as 0.5 percent water,
based upon the weight of the polyglycolic acid; for a preferred
storage life, the water or moisture content should be as low as
0.05 percent or less. With the small quantities of polyglycolic
acid in a suture package, the total quantity of water is best
described as bone dry. Exotic analytical techniques are required to
detect and measure the water content.
This invention relates to a storage stable package for an
absorbable sterile synthetic surgical element of a polymer subject
to hydrolytic degradation to non-toxic, tissue-compatible
absorbable components, such as a polyglycolic acid suture. More
particularly the invention relates to a package which comprises an
air tight sealed container fabricated from a material which is
substantially impervious to water vapor, the container having
therein said surgical element such as a polyglycolic acid suture
which is substantially free from water, i.e. bone dry. The gaseous
contents of the container are, prior to sealing the container,
either evacuated to yield a vacuum packaged suture or replaced with
a dry gas which is non-reactive with polyglycolic acid and which is
substantially free from water. A particularly suitable container
material is aluminum foil.
A variety of different packaging materials was evaluated in an
attempt to find a storage stable package for polyglycolic acid
sutures. For example, when the suture was packaged in Saran (a
vinyl chloride-vinylidene chloride copolymer) the suture had
totally disintegrated after only 42 days storage at 100.degree.F.
and 100 percent relative humidity. A similar result was observed
with Scotch Pak film. Scotch Pak is a laminate of polyethylene and
the polymeric ester of ethylene glycol and terephthalic acid. Other
package materials also failed to protect the suture from similar
adverse affects.
Prior to sealing the suture within the package of this invention,
it is essential that the suture be bone dry. The suture can be
rendered bone dry by heating for a sufficient period of time to
remove the water therefrom. However it must be noted that once this
water is removed, the suture cannot be allowed to contact an
environment containing moisture for even a very brief period of
time, since even such a brief contact can cause severe
deterioration of suture package and in-vivo strength after the
suture is sealed in a water impervious container and stored for a
prolonged period of time. It therefore becomes necessary when a
processing gap between when the suture is dried and when it is
packaged is anticipated to provide for interim storage in a dry
area where the possibility of contact with moisture is
eliminated.
This invention also relates to a method for preparing a storage
stable package containing therein a sterile polyglycolic acid
suture. Such a package is prepared by inserting the suture into a
container which is substantially impervious to water vapor,
sterilizing the suture and container, removing substantially all of
the water from the sterilized suture, and then maintaining the
dried sterilized suture in a substantially dry environment until
the container is to be sealed. Prior to sealing the container, the
gaseous contents thereof are either evacuated or replaced with a
gas which is non-reactive with polyglycolic acid and which is
substantially free from moisture.
This invention also relates to a method for sterilizing an
absorbable polyglycolic acid with ethylene oxide vapor without
adverse effect upon the package or in-vivo strength of the suture.
In accordance with this process, a non-sterile polyglycolic acid
suture is contacted with a gas having as its active component
ethylene oxide. The gas is maintained at a temperature of from
about 70.degree. to 90.degree. F. The moisture content of the gas
is the ambient moisture content and no additional water is added to
the gas to establish any required relative humidity therein. When a
non-sterile polyglycolic acid suture is contacted with the gas
described above, sterility of the suture can be achieved with a
contact time of about 4 hours or more. Suitable sterilization is
achieved when the pressure of the sterilizing gas is maintained at
about 5 to 30 lbs. psig.
Previous gaseous ethylene oxide sterilization procedures have
called for a sterilizing gas maintained at a relatively high
pressure (25 psig) and high temperature (120.degree.-130.degree.
F.). Ordinarily, a prescribed relative humidity (i.e. 50 percent)
is achieved by adding to the gas that amount of water which is
required to establish the desired relative humidity at the
temperature of sterilization. Contact times of 20 hours or more are
ordinarily used. In view of the aforementioned adverse effect of
water, and especially of the effect of water coupled with high
temperatures, upon polyglycolic acid, it becomes apparent that
sterilizing polyglycolic acid sutures by such extreme conditions of
pressure, temperature, relative humidity as previously used for
prolonged periods of time would be most undesirable. It is known
that when polyglycolic acid is contacted with water, and
particularly at high temperatures, that degradatio of the polymer
will occur quite rapidly. The sterilization process of this
invention permits polyglycolic acid sutures to be sterilized at
significantly lower temperatures and pressures and shorter time
cycles. Additionally, since no moisture is deliberately added to
the sterilized gas and since the compounds of the sterilized gas
are anhydrous, the amount of moisture present in the sterilized
chamber is significantly less than would be available using prior
ethylene oxide sterilization techniques. Applicant has found that
polyglycolic acid sutures can be sterilized using the process of
this invention without adverse effects upon the package or in-vivo
properties of the suture.
BRIEF DESCRIPTION OF THE DRAWING
FIG. 1 is a frontal view of a preferred embodiment of the suture
package of this invention.
FIG. 2 is a sectional view taken along the line 2--2 of FIG. 1 and
serves to illustrate the laminate structure of a preferred water
impermeable container for the polyglycolic suture.
FIG. 3 is a schematic flow sheet depicting a process for preparing
the storage stable polyglycolic acid suture package of this
invention.
FIG. 4a shows the effect of the interim conditions which exist
between drying the suture and packaging the suture in the package
of this invention upon package straight pull of the suture after
storage at 132.degree.F.
FIG. 4b shows the effect of the interim conditions which exist
between drying the suture and packaging the suture in the package
of this invention upon 15 day in-vivo straight pull after storage
at 132.degree.F.
FIG. 5a compares the storage capabilities of the package of this
invention with those of an acceptable catgut suture package under
storage conditions of 100.degree. F. and 100 percent relative
humidity.
FIG. 5b compares the storage capabilities of the package of this
invention with those of an acceptable catgut suture package under
storage condition of 132.degree.F. and 10 percent relative
humidity.
FIG. 6 shows a suture on a reel label in a single strippable
envelope.
FIG. 7 shows several separate reel labels packaged in a single
strippable envelope.
FIG. 8 shows several moistureproof envelopes packaged in an outer
sterile strippable envelope.
DESCRIPTION OF THE PREFERRED EMBODIMENTS
FIGS. 1 and 2 present a preferred embodiment of the package of this
invention. Referring to these figures, the package comprises sealed
envelope 11 containing therein sterile needled polyglycolic acid
suture braid 12 wrapped around paper mounting 13. The package is
sealed by peripheral heat seal 14. The material from which envelope
11 is fabricated is a four layered water impervious laminate as
best seen by reference to FIG. 2. The laminate comprises a first
layer 15 of heat sealable polyethylene, a second layer 16 of
aluminum foil, a third layer 17 of polyethylene and a fourth layer
18 of printable paper. Envelope 11 is conveniently formed by
placing two pieces of the aforementioned laminate on top of each
other with heat sealable polyethylene layers 15 contacting each
other. Three of the four edges are then sealed together using a
standard heated die to form an envelope into which mounted suture
12 is inserted. After evacuating the contents of the envelope or
replacing them with an anhydrous inert gas, the fourth edge of the
envelope is sealed to produce a completely sealed package.
Polyethylene layer 15 is preferably comprised of 15 lb. low density
polyethylene having a thickness of about 1.5 mils. The function of
this layer is to provide a vehicle for heat sealing the package; of
course, any other suitable heat sealable thermoplastic which will
achieve this goal is also suitable. Examples of such other
materials are Saran medium and high density polyolefins,
tetrafluoroethylenes, and such.
Aluminum foil layer 16 should have a thickness of at least about
0.35 mils in order to insure suitable water barrier properties with
preferred thicknesses of about 0.35 to 1.5 mils and a highly
preferred thickness of about 0.5 mils.
Polyethylene layer 17 preferably has a thickness of about 0.5 mils.
Its function is to serve as an adhesive vehicle for joining
together aluminum layer 16 and paper layer 18. Of course, any other
suitable adhesive would be operable.
Paper layer 18 is preferably 25 lb. super-calendered Bleached Pouch
Paper (Virgin Sulphate Pulp) having a thickness of about 1.1 mils
.+-. 20 percent. The function of paper layer 18 is to permit direct
printing of labels and such on the external surface of the package
and hence any printable paper would be suitable.
A particularly suitable laminate of polyethylene-aluminum
foil-polyethylene-paper is available from the Riegal Paper Corp.,
New York, N.Y., under the trade designation of Pouchpak.
A convenient method for preparing the package of this invention is
shown schematically in FIG. 3. Referring to FIG. 3, surgical needle
19 is affixed to braided polyglycolic acid suture 20 to produce
needled polyglycolic acid suture braid 12. Braid 12 is then wrapped
around suture mounting 13. The mounted suture is laced in envelope
11, said envelope being prepared as described above.
Envelope 11 containing mounted suture 12 is then placed within a
sealed container which is permeable to sterilizing gas but not to
bacteria. This container is then placed in a suitable ethylene
oxide sterilizing oven. The oven is evacuated after which a mixture
of 12 percent by volume ethylene oxide and 88 percent by volume
dichlorodifluoromethane (Freon 12) is admitted to the oven. The
oven pressure is raised to about 10 psig by admitting more of the
gas mixture. The temperature of the gas mixture is maintained at
70.degree.-90.degree.F. The ethylene oxide-Freon mixture is
non-flammable and explosion proof and is safe in all proportions
when mixed with air. The Freon is essentially a diluene and, of
course, other suitable diluents such as carbon dioxide or other
members of the Freon family and their mixtures are also quite
suitable. The important aspect about the sterilization process is
that the polyglycolic acid suture can, surprisingly, be sterilized
in a relatively dry environment at low temperatures, moderate
pressures, and with very brief sterilization time cycles.
After the suture has been in contact with the sterilizing mixture
for at least 4 hours and preferably 8 hours, the sealed container
containing suture 12 is removed from the ethylene oxide oven and
placed in a drying oven whereupon it is heated at 180.degree. to
188.degree.F. for one hour under a 26 inch vacuum. Sterility of the
suture is maintained during this drying step since bacteria cannot
permeate the container surrounding suture 12. The container having
suture 12 therein is then stored in a dry area 21, i.e., an
environment substantially free from moisture, until the final
sealing of envelope 11. At this point the bacteria proof container
containing envelope 11 and suture 12 is removed from the dry area
21 and transferred into sterile area 22 whereupon envelope 11
containing suture 12 is removed from its bacteria-proof container.
The gaseous contents of envelope 11 are evacuated in sterile area
22 and envelope 12 is heat sealed to produce an air-tight vacuum
packaged polyglycolic acid suture. Alternately in sterile area 22,
the gaseous contents of envelope 11 can be replaced by an anhydrous
gas which is inert towards polyglycolic acid such as nitrogen,
argon, xenon, helium, hydrogen, carbon dioxide, air, or the like
after which envelope 11 is heat sealed to produce a non-vacuum
packaged polyglycolic acid suture. Sealed envelope 11 is then
removed from sterile area 22 and inserted into folded plastic sheet
23. Sheet 23 is heat sealed around envelope 11 by means of
cathedral seal 24 to form outer strippable envelope 25 containing
therein sealed, suture containing, inner envelope 11. A variety of
materials is suitable for use as outer strippable envelope 25. For
example various plastic, paper, and metallic foil materials can be
used for this purpose. A particularly suitable material for use as
outer envelope 25 is described in U.S. Pat. No. 2,949,181 said
patent herein incorporated by reference. The dual envelope suture
package is then placed in an ethylene oxide oven in order to
sterilize the outer surfaces of envelope 11, the inner surface of
envelope 25 and the void volume defined by said surfaces. The
ethylene oxide vapor permeates outer envelope 25 to achieve this
sterilization. The mechanics of this sterilization step are well
known and are outlined in greater detail in U.S. Pat. No.
2,917,878, said patents herein incorporated by reference. When
sterilization is complete a storage stable polyglycolic acid suture
package is provided which is entirely sterile except for the outer
surface of envelope 25. Such package is particularly suitable for
serving a sterile suture to a surgeon for use.
In reference to the above process, it is apparent that the sequence
and nature of the process steps can be changed somewhat without
effecting the nature of the finished packaged product. For example,
suture 12 and envelope 11 may be separately sterilized and then
assembled in sterile area 22. Alternatively, suture 12 contained in
envelope 11 can be vacuum dried prior to sterilization except that,
in that event, a subsequent drying step would be required if any
moisture was picked up by suture in the sterilization process.
Also, suture 12 can be dried prior to inserting it into envelope
11. Of course, a variety of sterilization techniques can be used
such as heat sterilization, X-rays, beta or gamma radiation and
such. However, the preferred method of sterilization is by gaseous
ethylene oxide. Such variations in the sequence and nature of the
process steps are apparent to those skilled in the art and are
deemed to fall within the scope of the claims appended hereto.
The polyglycolic acid suture itself may be in any form whatsoever
such as a multifilament braid or a monofilament. It may further be
needled, dyed, coated, or otherwise treated in accordance with
standard suture techniques.
Data are presented in Table I which indicate the effect of various
storage conditions upon the package and in-vivo strength of
polyglycolic acid sutures stored in the package of this invention.
##SPC6##
Values are presented as the percent of the original strength
retained. In reference to package properties, this terminology
means that on day zero of the storage period, the package strength
of a control (packaged) suture was measured. As storage time
progressed, package strength (i.e., knot pull and straight pull)
was measured at prescribed intervals and compared to the value of
the control package strength on day zero to give a "percent of
strength retained." In reference to in-vivo strength, this
terminology means that a control suture (no storage time) was
implanted on day zero of the storage period in a rabbit for periods
of 7 or 15 days after which the rabbit was sacrificed and the
suture removed. The tensile strength of the removed suture was then
measured and used as a standard control. As storage progressed,
sutures at prescribed storage intervals were implanted in rabbits
as described above and their strength measured after 7 or 15 days.
This strength was then compared to the strength observed with the
control suture from day zero to give a "percent of strength
retained."
The data of Table I show the effect of various storage conditions
upon the package and in-vivo straight pull of a size 3-0 and 1-0
suture. The strength retention both in the case of package and
in-vivo properties is generally satisfactory over all the
conditions studied except at 132.degree.F. and 10 percent relative
humidity. The data clearly indicate the extremely rapid
deterioration in suture strength to be expected even with the
preferred package of this invention when the relative humidity on
the outside of the package is low while the temperature on both the
inside and outside of the package is high. The data also indicate
that where temperatures are low but the external relative humidity
is high, satisfactory storage can be achieved. An analysis of these
data show that the package of this invention adequately prevets the
moisture existing in either a high or low moisture environment
surrounding the package from contacting the suture therein.
However, as storage temperatures are raised, rapid deterioration of
the suture strength, and in particular the in-vivo strength of the
suture, occurs despite the ability of the package to prevent the
entry of moisture into the contents of the package.
Data are presented in Table II which indicate why such rapid
deterioration of suture properties occurs after storage at
132.degree.F. Certain of these data are presented in FIG. 4a
(package straight pull) and FIG. 4b (15 day in-vivo straight pull)
and clearly indicate the importance of keeping the suture dry up to
the point of packaging it in the package of this invention if
suture strength is to be retained during prolonged storage at
elevated temperatures such as 132.degree.F. ##SPC7##
The data of Table II detail a study of the effect of the interim
conditions to which the suture is exposed between when it is dried
and when it is sealed in the package of this invention. In one
case, the dried suture was exposed to an environment maintained at
room temperature but having 50 percent relative humidity for 24
hours. The envelope containing the suture was then sealed, packaged
in any outer strippable envelope, and stored at 132.degree.F. and
10 percent humidity; after only one week storage at these
conditions, the suture had retained virtually no in-vivo strength
while simultaneously its packaged strength had severely
deteriorated.
In another case a dried suture was stored in a container at room
temperature in an environment having 20 to 30 percent relative
humidity. The suture was then packaged as above. The same rapid
deterioration in suture strength which was noted with interim
storage under conditions of 50 percent relative humidity was also
observed in this case.
In a final case, the dried suture was removed from the drying oven
and immediately placed in a dessicator where it remained until
sealed in its ackage. As can be seen from FIGS. 4a and 4b, after 6
weeks storage at 132.degree.F., the package and in-vivo strength
retention of the sutures were at satisfactory levels. Storage for
one week at 132.degree.F. and 10 percent relative humidity is
equivalent to storage for one year at 72.degree.F. and ambient
humidity.
The above results are provided to clearly indicate the importance
of preserving the suture in a dry state once it has been dried
until it is sealed within its water-impervious package. In some
cases, even very brief exposure of dried sutures to moist
environmental conditions has, surprisingly, produced extremely
rapid deterioration of suture strength when the sutures are
subsequently packaged and stored, particularly when storage occurs
under conditions of high temperature which accelerate the
undesirable effect upon the polyglycolic acid suture.
Table III presents data which compares the storage capabilities of
the package of this invention with those of a typical package which
is in widespread use for catgut sutures under various storage
conditions. The catgut package referred to is that described in
U.S. Pat. No. 2,917,878. ##SPC8##
The data of Table III are presented in FIGS. 5a and 5b. Referring
to these Figures, it is noted that at both storage conditions
studied (i.e. 100.degree.F. -- 100 percent relative humidity and
132.degree.F. -- 10 percent relative humidity), the storage
capabilities of polyglycolic acid sutures with respect to both
package and in-vivo strength were at least equal to that of catgut
sutures and, in fact, appear to be somewhat better.
The data shown in FIGS. 5a and 5b serve to clearly indicate the
ability of the package of this invention to provide prolonged
stable storage of absorbable polyglycolic acid surgical
sutures.
FIG. 3 shows a single moistureproof package containing a single
polyglycolic suture being packaged in a single strippable outer
envelope 25.
As shown in FIG. 8, if surgical procedures consistently require
several sutures of a given size or pattern of sizes and needle
types to be used at about the same time, several sealed
moistureproof envelopes 26, 27 and 28 containing a suture may be
sealed in a sterile strippable outer envelope 29 for simultaneous
transfer to a sterile operating area and release.
As shown in FIG. 7 also several individual sterile absorbable
polyglycolic acid sutures, not necessarily the same size, on
several reels, 30, 31, 32 may be packed in a single moistureproof
envelope 33 for substantially simultaneous serving the several
sutures to a surgeon. The packaging of a single suture in a single
moistureproof envelope to be served from a single strippable
envelope permits greater flexibility and adaptability in operating
room techniques--but is by no means the only system of serving
sutures to the surgeon.
For instance, three 36 inches lengths of size 2-0 polyglycolic acid
braided sutures, each having a medium size 1/2 circle taper point
needle and packaged on separate paper mountings 13, or reels, are
packaged in a single sealed moistureproof envelope for surgical
repair after childbirth. The group of three is often used for the
surgical procedure, and can conveniently be served together. A
back-up supply of other sizes, and needle configurations is
available on short notice from the operating room supply as
needed.
A group of three 18 inches lengths of unneedled suture braid size
3-0 are conveniently packaged together to be used as ligatures in
surgery. A plurality of bleed points often requires several
tie-offs.
Present operating room techniques are adapted to the presentation
of a sterile inner moistureproof envelope, with release of the
suture from this sterile inner envelope at time of use.
As shown in FIG. 6 another economical serving technique is for the
moistureproof envelope 36 itself to be the sterile barrier, as well
as the moisture barrier, with the reel-label 35 having the
individual sutures wound thereon. Types of such reel-labels are
shown in U. S. Pat. No. 3,357,550, Holmes & Murphy, Combination
Reel and Label for Surgical Sutures, Dec. 12, 1967. One or more
such reel-labels carrying sutures permits individual sutures to be
served from reels when needed, but the single envelope permits
smaller packages, and economy of packaging materials. Because
polyglycolic acid sutures do not require a tubing fluid, an inner
envelope to hold such fluid is traditional but anachronistic, and
can be eliminated, as surgical procedures in the operating room are
adapted to these streamlined packaging concepts.
Whereas this invention is particularly described in reference to
sutures, including ligatures, other polyglycolic acid surgical
elements such as described in Schmitt and Polistina U.S. Pat. No.
3,463,158 "Polyglycolic Acid Prosthetic Devices," must be packaged
in a dry environment for long term storage stability, with
retention of full strength. This patent describes reinforcing
elements such as fabrics for tissue reinforcement or arterial
splices which consists in part of polyglycolic acid and in part of
non-absorbable filaments designed for long term emplacement and
retention in tissue elements.
For surgical items in which strength is not significant, dry
storage is not required. For example for a glove powder, to dust
surgical gloves, the material is already in powdered form, and if
the powder has low strength, and is rapidly absorbed, the product
is completely acceptable.
Similarly, if a surgical element, such as a heart valve, is to be
used within a few days of manufacture, dry storage is not required.
Also, storage at low temperatures, as for example in a refrigerator
or freezer, gives longer useful life, and sutures can be stored
even if not dry, for a useful period if kept cool.
Usually, dry packaging to give a useful shelf life of at least
three years to five years at room, shipping, and warehouse
temperatures is preferred, as controlled storage conditions can add
to costs.
Also it is desirable that for surgical supplies, all precautions to
supply the highest standard of product under all conditions be
used. Hence a product with short term or special storage
characteristics should not be used where modern packaging
techniques permit greater storage stability.
A unique and unexpected additional advantage of the present
moistureproof package is that the needles never rust. Carbon steel
needles often rust in tubing fluid, and additives to prevent rust
are sometimes used. Here the package is moisture free, and rusting
on storage is no longer a problem.
An additional advantage of vacuum packaging in foil is that the
outline of the suture and needle show through the foil laminate. If
the foil laminate as supplied has a pinhole in it, the loss of
vacuum changes the shape of the package permitting visual
inspection.
Other hermetic packages can be used, such as sealed glass tubes,
sealed tin cans, and the like, but such packages are more expensive
and less convenient than a foil laminate package.
The determination of the moisture content of polyglycolic and
sutures in their envelopes is quite exotic. Certain samples were
run in which 0.2 gram of a sample was sealed in a moistureproof
envelope of the type herein described and the quantities of
moisture were determined.
0.02 percent of moisture, based on the weight of the suture is 200
parts per million by weight and with 0.2 grams of sample,
corresponds to 40 micrograms of water.
Polyglycolic acid suture braid is hygroscopic and absorbs water
from its environment even during the transfer to analytical
equipment to determine moisture content.
Certain analyses were made on a CEC/Analytical Instruments Division
of Bell & Howell Corporation Type 26-321A Moisture Analyzer
which reads to 0.1 micrograms of water on a digital readout. This
device uses an electrolytic cell with a phosphorous containing
electrolyte to absorb water and measures the amount of electricity
required to electrolyze the absorbed water. Dry nitrogen is swept
over a sample heated to 125.degree.C., which takes up the water
with the water being absorbed from the nitrogen in the electrolytic
cell, which is then electrolyzed. With a suitable conversion factor
this gives direct reading of the quantity of water.
Inasmuch as the polyglycolic acid itself as well as the paper label
are organic, high temperatures will decompose the materials to
yield water even though the water is not present as such at lower
temperatures.
Results obtained appears internally consistent, and were consistent
with those found by radio-tracer techniques in which the
polyglycolic acid was exposed to tritiated water, for various
lengths of time, and the water content computed from scintillation
count of tritium decay.
The difficulty with accurate analysis can be illustrated by results
in a test in which 0.2 gram of polyglycolic acid suture braid was
transferred from the moistureproof envelope to a sample chamber for
moisture analysis. With a dry braid, with the sample exposed for 5
seconds during the transfer to ambient room conditions of 48
percent relative humidity and 70.degree.F., temperature, the braid
absorbed 0.037 percent moisture. With a 15 second transfer, the
braid absorbed 0.076 percent moisture. With an exposure of 35
minutes, the moisture rose to 0.39 percent. Because of the almost
universal occurence of moisture, and its innocuous presence under
so many conditions, conditions under which its effect is
deleterious are difficult to ascertain, and difficult to measure.
Chemistry in a moisture free environment is indeed a rare and
exotic phase of science.
A series of tests were run to determine how much moisture is
absorbed by the suture braid from the ambient atmosphere, and the
effect of moisture on the sutures. A group of sutures were prepared
using a size 2-0 braid with a blank reel label in each envelope. In
each moisture-proof foil laminate envelope were placed two suture
lengths of about 7 feet 2 inches to give approximately 0.2 grams of
braid in each suture length, with two such lengths in each
envelope. The sutures were cut, wound, tied in bundles and weighed.
A group of envelopes containing sutures were placed in a fiber
glass cloth sleeve, as a bacteria shield and sterilized with a 12
percent ethylene oxide, 88 percent Freon 12 mixture for 10 hours at
20 pounds gauge and ambient temperature. After sterilization, the
sutures were vacuum dried for 2 1/2 hours at a temperature of about
80.degree.C. and less than 1 millimeter mercury total pressure.
Immediately after vacuum drying, the envelopes were placed in
moisture chambers at 72.degree.F. containing the relative humidity
indicated in the table. These relative humidities were chosen to
use convenient salt mixtures which maintain the indicated relative
humidity. The envelopes were permitted to equilibrate for 72 hours,
protected by the fiber glass cloth sleeve to keep the packages
sterile, after which under sterile conditions, the fiber glass
cages were opened and the envelopes sealed. The sealed foiled
envelopes with their moisture equilibrated contents were then
packed in an outer strippable polyesterpolytheylene laminate
package which was sterilized through the laminate for 18 hours at
125.degree.C. at 26 pounds gauge pressure after which the test
packages were either used for immediate tests, or stored at
56.degree.C. with ambient relative humidity for 1, 3 and 6 weeks as
shown in the table. The relative humidity of the ambient conditions
is essentially immaterial inasmuch as moisture does not pass into
or pass out of the sealed foil envelope and accordingly it is only
the temperature which is controlling.
Table IV following shows the moisture of the test chamber in which
each set of braid was dried and the approximate parts per million
of water in the atmosphere at 72.degree.F. ##SPC9##
As shown by Table IV, it can be seen that when the moisture content
is below about 0.05 percent by weight of moisture based on the
weight of the suture, even when stored for 6 weeks at 56.degree.C.,
the sutures still maintain a good knot strength and maintains good
strength on in-vivo straight pull tests. The in-vivo tests were
conducted by implanting the suture in rabbits for 15 days and then
removing the suture from the rabbits and determining the residual
strength. With the sutures in which the interior of package was too
moist, either the pull strength turned out to be essentially 0, or
in some marked NT the suture had degraded so far that no test could
be conducted because the suture was too weak to be emplanted in the
test animal.
The above test shows that a useful degree of strength for short
term storage can be obtained with as much as 0.5 percent moisture
in the envelope but for long term storage stability, it is
preferred that the moisture content be not greater than 0.05
percent. An even lower content of 0.02 percent of moisture based on
the weight of the braid in the envelope gives an extra margin of
safety for the storage stability of the package.
It is to be noted that the paper of the reel label can act as a
moisture trap and will also hold moisture which can aid in
degrading the suture if there is a comparatively high moisture
content in the envelope. Where the moisture in the envelope is
below about 0.05 percent, the amount of moisture absorbed on the
label is acceptably low and does not lead to degradation of the
suture. As the loss of strength is a function of the time and the
moisture, the higher moisture content is acceptable where it is
known that the storage life requirements are for short duration of
storage only. It is preferable that the moisture content is kept
below 0.05 so that the sutures in their envelopes are storage
stable for a period of years, which insures sutures remaining in
hospitals for a prolonged length of time before use are still
good.
The six weeks tests at 56.degree.C. is regarded as being equivalent
to at least 3 years storage under ambient conditions which would
include warehouses, shipping conditions and hospital storage and is
regarded as probably equal to at least 5 years storage under such
transient conditions.
Because the temperature of the storage can vary considerably,
depending upon whether the suture is stored in a tropical climate
such as Bombay, India, or one of the cooler Alaskan regions, the
worst case must be considered as controlling in order that the
suture will stand up under the worse set of conditions for a
desirable length of time, at least 3 to 5 years, and will stand up
under less demanding storage conditions for extended periods.
A moisture content of below about 0.05 percent water by weight of
the polyglycolic acid braid can be considered as essentially bone
dry. This permits sealing the dried suture containing envelopes at
a relative humidity of about 2.5 percent at 72.degree.F., which
corresponds to about 450 parts per million of water in the air. A
preferred operating range is about 50 parts per million, so that
even if complete equlibration is not attained, the sutures are
storage stable for at least 5 years.
In accordance with the usage set up by the Federal Trade
Commission, and set forth in Title 16 of the Code of Federal
Regulations, pages 462 and 463 of the 1972 edition, fibers are
generally classified with the generic name if they contain over 85
percent content of one monomer. Here the term polyglycolic acid
indicates at least 85 mol percent glycolic acid linkages. The term
homopolymeric is used to indicate 100 percent glycolic content,
where the meaning may be ambiguous.
As the package strength characteristics approximate the inherent
viscosity of the polymer, it is often convenient to measure the
inherent viscosity of polymers in powdered form rather than
extruding and spinning to form a fiber, and sutures.
Good surgical elements are obtainable if the inherent viscosity is
at least about 0.4. Very high grade sutures are obtained if the
inherent viscosity of the polymer is at least about 1.0. Polymers
with an inherent viscosity of about 1.4 are hard to spin, as
extrusion requires normally high pressures, but make a superior
quality of suture with very good 21 day strengths on
implantation.
Tests were run on a group of polymers of about the same inherent
viscosity, with varying ratios of moles of glycolide to moles of
lactide. The following Table V shows the inherent viscosity after
the listed number of days when the polymer is powdered form was
stored in either sealed envelopes, or opened envelopes at a
temperature of 100.degree.F. and relative humidity of 100 percent.
##SPC10##
As can be seen from thee data, the longer the storage in open
envelopes, the more the polymer is degraded, the less satisfactory
the suture characteristics.
Animal implantation tests on sutures made from such polymers
confirm the pattern.
In general, any exposure to moisture vapor tends to degrade the
polymer, causing lower strength, and more rapid absorption.
When protected by the packages of this invention and kept dry, a
storage life of at least five years under all reasonable commercial
storage conditions is to be expected. If during processing and
storage, the sutures are permitted to stand with absorbed moisture,
the storage life is decreased, and the in vivo strength is
reduced.
Obviously for uses which do not require strength, such as a
surgical powder, storage requirements are less rigorous. Where
strength is desired, moisture is to be excluded and bone dryness
for storage is preferred for all products in which hydrolytic
degradation of glycolic acid ester linkages results in tissue
absorption. The present package maintains such dryness for at least
several years.
* * * * *